SocraTec R&D GmbH
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h) (NCT05883124) | SocraTec R&D GmbH | 2023-04-17 |
| Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease (NCT06247410) | SocraTec R&D GmbH | 2021-08-23 |
| Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration (NCT04790136) | SocraTec R&D GmbH | 2021-03-17 |
| S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet (NCT04505787) | SocraTec R&D GmbH | 2020-07-24 |
| Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase (NCT03573050) | SocraTec R&D GmbH | 2018-05-16 |
Track SocraTec R&D GmbH automatically
Every clearance here is in the API, with alerts when new ones post.